Characteristic | Before PSM (n = 963) | After PSM (3:1) (n = 628) | ||||
---|---|---|---|---|---|---|
MAPV ≤ 2.17 (n = 716) | MAPV > 2.17 (n = 247) | SMD | MAPV ≤ 2.17 (N = 471) | MAPV > 2.17 (n = 157) | SMD | |
Age, year | 79.0 (73.0,84.0) | 80.0 (73.0,85.0) | 0.076 | 81.0 (75.0, 85.0) | 81.0 (74.0, 85.0) | 0.001 |
Sex (female), n (%) | 534 (74.6) | 195 (78.9) | 0.104 | 353 (74.9) | 123 (78.3) | 0.080 |
BMI, kg/m2 | 22.6 (19.5,25.4) | 23.4 (20.8,25.7) | 0.171 | 22.9 (19.6, 25.8) | 23.4 (20.6, 25.4) | 0.034 |
Smoking, n (%) | 59 (8.2) | 18 (7.3) | 0.036 | 44 (9.3) | 14 (8.9) | 0.015 |
ASA stage (> II), n (%) | 359 (50.1) | 154(62.3) | 0.248 | 279 (59.2) | 92 (58.6) | 0.013 |
Alcohol consumption, n (%) | 43 (6.0) | 15 (6.1) | 0.003 | 28 (5.9) | 9 (5.7) | 0.009 |
Major coexisting conditions | ||||||
COPD, n (%) | 42 (5.9) | 5 (2.0) | 0.198 | 18 (3.8) | 4 (2.5) | 0.073 |
Diabetes mellitus, n (%) | 246 (34.4) | 88 (35.6) | 0.027 | 167 (35.5) | 56 (35.7) | 0.004 |
Hypertension, n (%) | 389 (54.3) | 133 (53.8) | 0.010 | 259 (55.0) | 83 (52.9) | 0.043 |
Cardiovascular diseases, n (%) | 144 (20.1) | 47 (19.0) | 0.027 | 103 (21.9) | 30 (19.1) | 0.068 |
Cerebrovascular disease, n (%) | 154 (21.5) | 78 (31.6) | 0.230 | 121 (25.7) | 40 (25.5) | 0.005 |
Dementia | 12 (1.7) | 8 (3.2) | 0.101 | 7 (1.5) | 3 (1.9) | 0.033 |
Surgical conditions | ||||||
Anesthesia method, n (%) | 0.698 | 0.015 | ||||
Regional | 481 (67.2) | 99 (40.1) | 274 (58.2) | 92 (58.6) | ||
General | 115 (16.1) | 114 (46.2) | 114 (24.2) | 37 (23.6) | ||
Regional + General | 120 (16.8) | 34 (13.8) | 83 (17.6) | 28 (17.8) | ||
Fracture type, n (%) | 0.093 | 0.041 | ||||
Intertrochanteric | 311 (43.4) | 96 (38.9) | 202 (42.9) | 70 (44.6) | ||
Femoral neck | 400 (55.9) | 149 (60.3) | 264 (56.1) | 85 (54.1) | ||
multiple locations | 5 (0.7) | 2 (0.8) | 5 (1.1) | 2 (1.3) | ||
Duration of surgery, min | 100.0 (80.0,120.0) | 95.0 (75.0,120.0) | 0.024 | 100.0 (80.0, 120.0) | 95.0 (75.0, 115.0) | 0.076 |
Emergency surgery, n (%) | 14 (2.0) | 4 (1.6) | 0.025 | 9 (1.9) | 2 (1.3) | 0.051 |
Drug usage | ||||||
Benzodiazepines, n (%) | 462 (64.5) | 151 (61.1) | 0.070 | 294 (62.4) | 92 (58.6) | 0.078 |
Dexmedetomidine, n (%) | 156 (21.8) | 39 (15.8) | 0.154 | 84 (17.8) | 29 (18.5) | 0.017 |
Glucocorticoids, n (%) | 213 (29.7) | 104 (42.1) | 0.260 | 161 (34.2) | 57 (36.3) | 0.044 |
Droperidol, n (%) | 99 (13.8) | 26 (10.5) | 0.101 | 63 (13.4) | 18 (11.5) | 0.058 |
Preoperative blood test | ||||||
WBC count, ×109/L | 6.9 (5.6, 8.6) | 7.2 (5.5, 8.4) | 0.009 | 6.9 (5.5, 8.6) | 7.0 (5.5, 8.8) | 0.024 |
RBC count, ×1012/L | 3.8 (3.4, 4.2) | 3.8 (3.4, 4.2) | 0.021 | 3.8 (3.4, 4.1) | 3.8 (3.3, 4.1) | 0.059 |
Platelet, ×109/L | 215.0 (167.8,265.0) | 222.0 (170.0,270.0) | 0.038 | 216.0 (167.0, 266.5) | 220.0 (171.0, 270.0) | 0.019 |
Albumin, g/L | 34.9 (32.2, 37.7) | 34.8 (32.4, 38.0) | 0.004 | 34.9 (32.4, 37.6) | 34.3 (32.5, 37.6) | 0.051 |
Creatinine, μmol/L | 64.2 (54.3, 76.3) | 63.70 (53.5, 78.6) | 0.079 | 64.8 (55.3, 78.7) | 63.5 (52.9, 78.7) | 0.041 |
Hemoglobin, g/L | 115.0 (103.0, 126.0) | 116.0 (103.0,127.5) | 0.019 | 114.0 (103.0, 126.0) | 115.0 (101.0, 127.0) | 0.065 |
Postoperative conditions | ||||||
POD, n (%) | 64 (8.9) | 51 (20.6) | 0.334 | 50 (10.6) | 37 (23.6) | 0.349 |